CUE · Cue Biopharma, Inc.

Summary

On February 9, 2026, Cue Biopharma, Inc. appointed Lucinda Warren, its current Chief Business Officer, as Chief Financial and Business Officer. Ms. Warren assumed the duties of principal financial officer and principal accounting officer effective immediately, with no additional compensation granted for the new roles.

Key takeaways

• Lucinda Warren appointed Chief Financial and Business Officer on February 9, 2026.
• Ms. Warren assumed duties of principal financial officer and principal accounting officer.
• Ms. Warren previously served as Chief Business Officer since September 2024.
• No additional compensation will be provided for assuming the new financial officer roles.
• No material changes were made to Ms. Warren's existing employment agreement.